Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer’s disease-Reference-Cited by-同舟云学术

Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer’s disease

Published:2021-11-27 Issue:6 Volume:12 Page:104-113
ISSN:1949-8454
Container-title:World Journal of Biological Chemistry
language:
Short-container-title:WJBC

Author:

Ikeda Yuka,Nagase Nozomi,Tsuji Ai,Kitagishi Yasuko,Matsuda Satoru

Publisher

Baishideng Publishing Group Inc.

Reference84 articles.

1. Therapies for Alzheimer's disease

2. Salidroside Attenuates Cognitive Dysfunction in Senescence-Accelerated Mouse Prone 8 (SAMP8) Mice and Modulates Inflammation of the Gut-Brain Axis

3. Increased vulnerability of brain to estrogen withdrawal-induced mitochondrial dysfunction with aging

4. Role of protein phosphatases and mitochondria in the neuroprotective effects of estrogens

5. Milk consumption and multiple health outcomes: umbrella review of systematic reviews and meta-analyses in humans

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Caveolae with GLP-1 and NMDA Receptors as Crossfire Points for the Innovative Treatment of Cognitive Dysfunction Associated with Neurodegenerative Diseases;Molecules;2024-08-20

2. Impact of alogliptin on lipopolysaccharide-induced experimental Parkinson's disease: Unrevealing neurochemical and histopathological alterations in rodents.;European Journal of Pharmacology;2024-07

3. Semaglutide as a potential treatment for obesity in Smith-Kingsmore syndrome (SKS) patients: A mosaic mutation case report;Obesity Research & Clinical Practice;2024-03

4. Dipeptidyl peptidase-4 inhibitors alleviate cognitive dysfunction in type 2 diabetes mellitus;Lipids in Health and Disease;2023-12-11

5. Natural plant materials as a source of neuroprotective peptides;Current Medicinal Chemistry;2023-07-03